Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Svoronos Dawn exercised options for 2,645 Xenon Pharmaceuticals Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Svoronos Dawn (Director) exercised options for 2,645 Xenon Pharmaceuticals Inc. shares, leaving 26,229 shares. Filed Jun 3, 2026 (Form 4).
- Options exercised
- 2,645 shares
- Holding after
- 26,229 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Shares | Option exercise | 2,645 | 27,645 | Direct | |
| Jun 1, 2026 | Common Shares | Shares withheld for tax | 1,416 | US$53.41 | 26,229 | Direct |
Source
Related
- Xenon Pharmaceuticals Inc.
- Svoronos Dawn
- Xenon Pharmaceuticals Inc. shareholders
- Form 4 · Svoronos Dawn · Sep 3, 2026
- Form 4 · Kelly Thomas Patrick · Oct 16, 2026
- Form 4 · Kelly Thomas Patrick · Oct 1, 2026
- Form 4 · Mortimer Ian · Oct 1, 2026
- Form 4 · Kenney Christopher John · Aug 31, 2026
- Form 4 · Gannon Steven · Aug 13, 2026